Beyond Bioequivalence: The Role of Super Generics and Value-Added Medicines
Competition in the German generic drug sector is moving beyond price wars and embracing innovation through Super Generics or Value-Added Medicines. These products are modified generic versions of off-patent drugs that offer distinct clinical or patient benefits. These improvements can include better drug delivery mechanisms, enhanced stability, or new formulations (e.g., a long-acting...
0 Comentários 0 Compartilhamentos 303 Visualizações 0 Anterior